Drugs
FDA Approves New Drug for Treating Most Common Type of Lung Cancer, Based on Broad Institute Research
The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the Broad Institute that treats non-small cell lung cancer — the most common type of lung cancer, which had until recently few treatments.
Opioid Overdoses, Deaths Decreased in Cambridge in 2024
Opioid overdoses and overdose-related deaths in Cambridge decreased in 2024 from the previous year, according to a report released by the Cambridge Public Health Department on Thursday.
Experts Debate Federal Legalization of Psychedelic Therapy at Harvard Law School Event
Experts on psychedelic use and drug regulation discussed whether psychedelic therapy should be legalized federally at a Wednesday event hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
69% of Freshman Class Entered College as Virgins, Survey Finds
The Crimson’s annual survey of the freshman class found that 69 percent of incoming students came to college without having had sexual intercourse, the highest reported percentage in 11 years.
Massachusetts Voters Weighed in on 5 Ballot Questions. Here’s What They Chose.
Voters approved a ballot measure to eliminate the MCAS exam as a high school graduation requirement but rejected pushes to legalize psychedelics and raise the minimum wage for tipped workers. The election also saw votes in favor of expanding the state auditor’s power to investigate the state legislature and allowing rideshare drivers to unionize.
Canadian Biotech Company to Supply MDMA for McLean Hospital Clinical Trial
Toronto-based MDMA manufacturer PharmAla Biotech signed a contract to supply researchers at McLean Hospital, an HMS-affiliated psychiatric teaching hospital, with the drug for a pending clinical trial, PharmAla announced in a Oct. 2 press release.
HMS Researchers Introduce AI Tool for Drug Repurposing
Harvard Medical School associate professor Marinka Zitnik and her lab announced the development of TxGNN, an artificial intelligence model which is able to suggest new treatment applications of existing drugs using neural networks.
Cambridge’s Weed Policy Prioritized Social Justice. Some Dispensary Owners Say It’s Left Them High and Dry.
Since legalizing marijuana for adult recreational use in 2018, Massachusetts has seen nearly $6 billion in recreational marijuana sales. But to some, Cambridge has failed to capitalize on this momentum.
Scammers Sold Fake CBD Gummies on Harvard Website, Snopes Reports
Scammers exploited a Harvard website in a ploy to sell “miracle” CBD and keto gummies, a Snopes investigation revealed on March 27.
Author Mike Jay Talks Religious and Scientific Perspectives on Psychedelics at Div School Webinar
Author and cultural historian Mike Jay discussed the role of psychedelics as a bridge between science and spirituality at a Monday webinar hosted by the Harvard Divinity School’s Center for the Study of World Religions.
Michael Pollan Talks Future of Psychedelics Research at Harvard Mahindra Humanities Center
Author Michael K. Pollan, a Harvard lecturer in English and professor of the practice in non-fiction, spoke about the future of research into the societal and cultural aspects of psychedelics during a Mahindra Humanities Center talk on Wednesday.
In Late 90s, Harvard Moved Toward ‘No Tolerance’ Smoking and Drinking Policies
Dean of the College Harry R. Lewis ’68 and Dean of Students Archie C. Epps III released a 16-clause statement outlining a strengthened alcohol policy on Oct. 22, 1997, leading to radical changes to Harvard’s alcohol and smoking rules in the late 1990s.
Experts Discuss Psychedelics Policy in the Global North at Harvard Law School Webinar
The Project on Psychedelics Law and Regulation at Harvard Law School’s Petrie-Flom Center hosted a virtual panel on psychedelics in Australia, Canada, the Netherlands, and the United Kingdom on Monday.
Legal Experts Discuss Regulation of Cannabis and Psychedelics at Petrie-Flom Center
A panel of legal experts discussed lessons the psychedelics industry can learn from the history of U.S. cannabis policy during a virtual event hosted by Harvard Law School’s Petrie-Flom Center.
Boston Man Sentenced to 10 Years for Fentanyl, Cocaine Delivered to Harvard Biology Lab
A Boston man was sentenced on Oct. 5 to 10 years in prison for conspiring to distribute fentanyl, heroin, and cocaine — some of which was delivered to a Harvard biology lab.
‘This Is Our Fight Against Cancer’: Researchers Find HIV Drug Promising for Cancer Treatment
Harvard researchers at Massachusetts General Hospital found that lamivudine, a commonly used drug for HIV treatment, showed promise in combating metastatic colorectal cancer.
Legal and Medical Experts Discuss Alternative Approaches for Aiding Families Struggling With Substance Abuse
Legal and medical experts discussed how to support families struggling with substance abuse in a Tuesday virtual panel jointly hosted by Massachusetts General Hospital's Center for Law, Brain, and Behavior and Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
Fahedur Fahed
Fahedur Fahed '22 has volunteered at the Harvard Square Homeless Shelter for eight years. Fahed carries Narcan with him so that he is prepared to respond to overdoses.
Jim Stewart
Jim Stewart, a Divinity School graduate, is the director of First Church Shelter in Cambridge. He would like to see Harvard increase its involvement in responding to the overdose crisis.
Jason B. Silverstein
Jason B. Silverstein is a lecturer at Harvard Medical School who has studied and written about opioid use. He advocates for harm reduction measures such as making Narcan available in public places.
Material Aid and Advocacy Program
A display for the Material Aid and Advocacy Program sits ready to welcome people to the organization's drop-in space. The Material Aid and Advocacy Program, located in Cambridge, supports people living in poverty or experiencing homelessness.
Policymakers Discuss Psychedelics Reform’s Far Out Future in HLS Webinar
Psychedelics reform advocates discussed decriminalizing drugs, reducing stigma, and centering Indigenous voices in a Harvard Law School webinar on Wednesday.
Massachusetts General Hospital Launches Center to Study Neuroscience of Psychedelics
Massachusetts General Hospital, an affiliate of Harvard Medical School, has launched a new center to study the clinical benefits of psychedelics in treating mental illness.
Following Local Successes, Cambridge State Rep. Puts Forward Bills on Controlled Substance Reform
Massachusetts State Rep. Michael L. Connolly, a Democrat who represents parts of Cambridge and Somerville, submitted two bills in the Massachusetts House last month aimed at reforming controlled substance laws.
Panelists Advocate for Psychedelics Decriminalization in Law School Webinar
Panelists advocated for the decriminalization of psychedelics to an audience of more than 200 people during a Wednesday webinar hosted by Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.
Most Read Articles
- 2
- 3
- 4
- 5
OUR LATEST PRINT EDITION
Fresh off the press every Friday, with special issues throughout the year. Want a copy? Find one near you. Want it delivered to your doorstep? Sign up.
The Harvard Crimson
Original reporting and exclusive scoops from Harvard and Cambridge — delivered straight to your inbox. Subscribe today.